Stock Events

Medlab Clinical Limited 

$4.7
0
-$11.05-70.16% Thursday 16:58

Statistics

Day High
0.11
Day Low
0.11
52W High
0.29
52W Low
0.11
Volume
10,000
Avg. Volume
-
Mkt Cap
22.32M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

29OctExpected
Q2 2021
Q4 2021
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
-1.8
-1.2
-0.61
-0.01
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDBBF. It's not an investment recommendation.

About

Pharmaceuticals: Major
Health Technology
Medlab Clinical Limited, a medical research and development facility, engages in the nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.
Show more...
CEO
Dr. Sean Michael Hall
Country
AU
ISIN
AU000000MDC8

Listings